Kovai Medical Center & Hospital share price today

Kovai Medical Center & Hospital Ltd's share price was ₹5,995.00 at the close on 4 November 2026. It has been rising for 16 weeks. That is 2.8% above its average price over the last 200 trading days.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Kovai Medical Center & Hospital Ltd is in stage 2. The phase helps read everything below.

In the last 52 weeks it traded between ₹5,098 and ₹6,233, and at that close it sat 79% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 11 weeks in a row.

Over the last 11 years the share price moved +816% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: revenue up on a year earlier for 11 quarters in a row (every quarter we can compare), profit up on a year earlier for 11 quarters in a row (every quarter we can compare) and highest quarterly profit in 15 quarters.

1. Revenue up on a year earlier for 11 quarters in a row (every quarter we can compare)

   In the June 2026 quarter revenue was ₹431 crore, +15.2% on a year earlier.

2. Profit up on a year earlier for 11 quarters in a row (every quarter we can compare)

   In the June 2026 quarter profit was ₹69 crore, +21.1% on a year earlier.

3. Highest quarterly profit in 15 quarters

   Profit of ₹69 crore in the June 2026 quarter is the highest of the last 15 quarters.

For April to June 2026 (the quarter ended 30 June 2026), Kovai Medical Center & Hospital reported revenue of ₹431 crore, up 15.2% from ₹374 crore a year earlier, and a profit of ₹69.0 crore, up 21.1% from ₹57.0 crore.

Kovai Medical Center & Hospital results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Kovai Medical Center & Hospital closed at ₹5,995.00 on 4 November 2026, down 3.2% from ₹6,190.30 a year earlier (7 November 2025) and up 261.9% over five years. Its highest weekly close since March 2016 was ₹6,685.10 on 24 October 2025.

Kovai Medical Center & Hospital share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

562 weekly closes from 11 March 2016 to 4 November 2026.

4 Nov 2026: Kovai Medical Center & Hospital closed at ₹5,995.00, up 3.2% on the week and down 0.1% on the month. 19 Aug 2026: ex-date for a dividend of ₹15 a share.

Earlier

• Results for April to June 2026: Revenue up 15.2% and profit up 21.1% on a year earlier.

Kovai Medical Center & Hospital paid ₹15 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.25% at the ₹5,995.00 close on 4 November 2026. The last was a dividend of ₹15 a share, ex-date 19 August 2026.

Kovai Medical Center & Hospital dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Yes. Kovai Medical Center & Hospital Ltd paid out 7% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

Kovai Medical Center & Hospital's management made 0 promises we could check against what it later reported.

Our read after the April to June 2026 results, written 22 August 2026.

What is changing at Kovai Medical Center & Hospital, from the latest results and calls: tertiary care demand density in western tamil nadu, operating leverage from medical college and bed additions and self-funding expansion cash profile.

• Tertiary Care Demand Density in Western Tamil Nadu. Regional dominance in Coimbatore drives inpatient volumes and surgical procedure mix across multi-specialty departments. ✓ fact
• Operating Leverage from Medical College and Bed Additions. Fixed medical infrastructure and teaching hospital assets convert incremental volume to profit at 27% to 29% operating margins. ✓ fact
• Self-Funding Expansion Cash Profile. 3-year cumulative operating cash flow of 1,041 Cr fully funds ongoing brownfield projects and allows debt reduction. ✓ fact
• Minimal Working Capital and Cash Collection Cycles. Debtor collection periods of 5 to 9 days keep the cash conversion cycle at 6 days, preventing capital lock-up. ✓ fact

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown.

Our read after the April to June 2026 results, written 22 August 2026.

A sustained deterioration in quarterly operating profit margin below 24% combined with debtor days expanding beyond 20 days or negative free cash flow for three consecutive quarters without planned capacity commissioning.

Each change stops working if

• Tertiary Care Demand Density in Western Tamil Nadu: New corporate hospital chains construct competing tertiary facilities in Coimbatore and dilute local patient market share.
• Operating Leverage from Medical College and Bed Additions: Clinical staff attrition or sharp medical supply cost inflation elevates fixed operating expenditure.
• Self-Funding Expansion Cash Profile: Major greenfield expansion outlays exceed operating cash generation and trigger renewed leverage.
• Minimal Working Capital and Cash Collection Cycles: Institutional or government scheme billing rises to a substantial portion of revenue with delayed reimbursement cycles.

The main risks

• Single-Cluster Geographic Concentration: Revenue and operational infrastructure are concentrated in Coimbatore, exposing cash flow to regional events. ⚠ estimate
• Regulatory Pricing Caps on Procedures and Consumables: Government interventions on healthcare package rates, stent prices, or insurance billing caps could compress margins. ⚠ estimate
• Capital Intensity of Future Hospital Expansion: Greenfield hospital expansions outside Coimbatore could incur extended gestation periods and drag return ratios. ⚠ estimate
• : Combined FII and DII shareholding of 5.13% and lack of shareholder concalls result in lower public market scrutiny. ⚠ estimate

Our read after the April to June 2026 results, written 22 August 2026.

When Kovai Medical Center & Hospital reports July to September 2026, these are the 5 checks that show whether the story is still on course. First: Quarterly operating profit margin declining below 26.0% or profit growth dropping below 10% on a year earlier.

Kovai Medical Center & Hospital is not on any of our India lists this week.

Kovai Medical Center & Hospital Ltd earned ₹69.0 Cr of net profit in the Jun 2026 quarter, +21.1% on the same quarter a year earlier. That is the 12th quarter in a row of profit growth. Full-year FY26 profit was ₹244 Cr. Over 10 years profit has grown 19.8% a year on average. That is 16.0% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned ₹57.0 Cr.

For the full year, FY26 profit was ₹244 Cr (+16.7% on the year before).

Why profit moved: revenue changed +15.2% on a year earlier and the margin moved +1.0 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +15.8% and revenue +14.9%. Profit and revenue are moving at about the same pace.

FY26-Q4. revenue ₹414 Cr and profit ₹63 Cr as reported.

FY27-Q1. revenue ₹431 Cr and profit ₹69 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

Kovai Medical Center & Hospital Ltd reported ₹431 Cr of revenue in the Jun 2026 quarter, +15.2% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 10 years it has grown 13.1% a year on average. The last full year, FY26, came in at ₹1,586 Cr.

Revenue is everything the company billed its customers in the period.

Why this happened. Kovai Medical Center functions as the primary referral hub for tertiary healthcare in Coimbatore, Erode, and Tirupur districts. Inpatient volume expansion and specialty complexity supported revenue growth from 344 Cr in Q2 FY25 to 431 Cr in Q1 FY27.

The last four reported quarters add to ₹1,644 Cr.

FY26 revenue was ₹1,586 Cr, +15.7% on the year before.

Recent pace: the last four quarters grew +14.9% on average, against 13.1% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +15.0%, against +14.2% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +15.8%, against +14.9% a year (stabilising).

FY26-Q4. revenue ₹414 Cr and profit ₹63 Cr as reported.

FY27-Q1. revenue ₹431 Cr and profit ₹69 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

Kovai Medical Center & Hospital Ltd's operating margin was 29.0% in the Jun 2026 quarter, 1.0 percentage points higher than the same quarter a year ago. Across 13 years it has been between 20.0% and 29.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +0.4 percentage points on the year while gross margin changed −0.7 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

FY26-Q4. revenue ₹414 Cr and profit ₹63 Cr as reported.

FY27-Q1. revenue ₹431 Cr and profit ₹69 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

Over the last 3 years, 164% of Kovai Medical Center & Hospital Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹362 Cr of operating cash against ₹244 Cr of profit. After ₹281 Cr of spending on assets, ₹81.0 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Why this happened. Direct cash and insurance-counter settlement models limit trade receivables. Debtor days stood at 9 days in FY26, supporting a working capital cycle of -58 days when factoring payables and customer advances.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 164% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle.

What to look at next: the bigger use of cash is spending on new assets, at 2.7× depreciation over three years. The next section checks what that spending is building.

Kovai Medical Center & Hospital Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 6 days in FY26, up from −2 days in FY21. It spent ₹797 Cr on assets over the last 3 years. Customers take 9 days to pay, and stock sits for 17 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹1,586 Cr, each day of that cycle ties up about ₹4.3 Cr, so roughly ₹26.0 Cr is tied up in the business at any time.

FY26: customers took 9 days to pay and stock sat for 17 days, about 0.6 months of sales sitting as stock, for a full cycle of 6 days, longer than FY21's −2.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 17 days. Customers pay about 9 days after that. Suppliers are paid at 20 days. Together that makes the 6-day cycle.

Spending on assets: ₹797 Cr over the last 3 years, against ₹299 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹135 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Kovai Medical Center & Hospital Ltd's P/E is 25.6×, near the high end of its own history: higher than 73% of past readings. Its usual P/E (the middle reading) is 19.8×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.